Literature DB >> 24297211

Novel chiral (salen)Mn(III) complexes containing a calix[4]arene unit in 1,3-alternate conformation as catalysts for enantioselective epoxidation reactions of (Z)-aryl alkenes.

Carmela Bonaccorso1, Giovanna Brancatelli, Francesco P Ballistreri, Silvano Geremia, Andrea Pappalardo, Gaetano A Tomaselli, Rosa M Toscano, Domenico Sciotto.   

Abstract

Two new chiral calix[4]arene-salen ligands 1a,b, based on calix[4]arene platforms in 1,3-alternate conformation, have been prepared by a new general synthetic pathway. Their Mn(III) complexes, 3a,b have shown fairly good efficiency in the asymmetric epoxidation of styrene and substituted styrenes, whereas excellent catalytic activity and selectivity were observed with rigid bicyclic alkenes, namely 1,2-dihydro-naphthalene and substituted 2,2'-dimethyl-chromene. The higher catalytic properties of 3a may be ascribed to the more rigid and inherently chiral structure as proved by molecular modelling, NMR spectroscopy and X-ray data of the similarly structured UO2 complexes 2a,b.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24297211     DOI: 10.1039/c3dt52550c

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Synthesis and characterization of some chiral metal-salen complexes bearing a ferrocenophane substituent.

Authors:  Angela Patti; Sonia Pedotti; Francesco Paolo Ballistreri; Giuseppe Trusso Sfrazzetto
Journal:  Molecules       Date:  2009-10-26       Impact factor: 4.411

Review 2.  Recent applications of chiral calixarenes in asymmetric catalysis.

Authors:  Mustafa Durmaz; Erkan Halay; Selahattin Bozkurt
Journal:  Beilstein J Org Chem       Date:  2018-06-08       Impact factor: 2.883

3.  (Salen)Mn(III) Catalyzed Asymmetric Epoxidation Reactions by Hydrogen Peroxide in Water: A Green Protocol.

Authors:  Francesco Paolo Ballistreri; Chiara M A Gangemi; Andrea Pappalardo; Gaetano A Tomaselli; Rosa Maria Toscano; Giuseppe Trusso Sfrazzetto
Journal:  Int J Mol Sci       Date:  2016-07-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.